0.0210USD+10.53%Mkt Cap: —P/E: —2d ago
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)1.71M $
Gross Profit1.18M $
Net Income (TTM)-12.15M $
Revenue/Share0.4790 USD
Last Price0.0210 USD
Fiscal Year End—
MR Quarter—
Employees18
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.01
EPS (TTM)—
EPS (Forward)—
52W Range
0.018621% of range0.0298
52W High0.0298 USD
52W Low0.0186 USD
Profitability
Gross Margin95.71%
Oper. Margin-616.42%
EBITDA Margin0.00%
Profit Margin-984.60%
ROE-116.65%
ROA-85.82%
Growth
Revenue Growth82.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.60M $
CapEx (TTM)—
FCF Margin-533.63%
FCF Yield—
Net Debt-6.83M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.05
Current Ratio1.89
Quick Ratio1.65
Book Value/Sh2.709 USD
Cash/Share1.579 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float4.36M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta-1.04
S&P 52W Chg18.16%
Avg Vol (30d)3.38K
Avg Vol (10d)—
Technical Indicators
RSI (14)38.3
MACD-0.0018
MACD Signal-0.0009
MACD Hist.-0.0009
BB Upper0.0352 USD
BB Middle0.0279 USD
BB Lower0.0206 USD
BB Width52.29%
ATR (14)0.0030 USD
Vol Ratio (20d)5.53x